PRO526 nucleic acids

Details PRO526 nucleic acids PRO526 nucleic acids

2008-05-13

2008-05-13

Saoud, Christine J. (Department: 1646)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023500, C435S235100, C435S325000, C435S320100, C435S069100, C530S350000

Reexamination Certificate

active

10897360

ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host ceolls comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

REFERENCES:
patent: 4847325 (1989-07-01), Shadel et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 6475753 (2002-11-01), Ruben et al.
patent: 6476212 (2002-11-01), Lalgudi et al.
patent: 6812339 (2004-11-01), Venter et al.
patent: WO 0109162 (2001-02-01), None
patent: WO 0151520 (2001-07-01), None
Wang et al. (Nuc. Acids Res. 27: 4609-4618, 1999; p. 4617.
Kaufman et al (Blood 94: 3178-3184, 1999).
Campbell et al. Theriology 47(1): 63-72, 1997.
Phillips, A., J Pharm Pharmacology 53: 1169-1174, 2001.
Hu, P. et al. GenEMBL locus AC007663, submitted May 27, 1999, Accessed Jan. 8, 2004.
Johnson, J. I., et al., “Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials”, British Journal of Cancer, vol. 84, No. 10, pp. 1424-1431, 2001.
Monks, Anne, et al., “Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines”, vol. 83, No. 11, Jun. 5, 1991.
Shi, Leming M., et al., :“Mining and Visualizing Large Anticancer Drug Discovery Databases”, J. Chem. Inf. Comput. Sci., vol. 40, pp. 367-379, Dec. 18, 1999.
Kobe and Deisenhofer, Trends Biochem. Sci., 19 (10):415-421 (Oct. 1994).
Iozzo, R. V. , Crit. Rev. Biochem. Mol. Biol., 32(2):141-174 (1997).
De La Salle, C., et al. Vouv. Rev. Fr. Hematol. (Germany), 37 (4):215-222 (1995).
Bernard-Soulier syndrome, Chlemetson, K. J., Thromb. Haemost. (Germany), 74(1):111-116 (Jul. 1995).
Ruoslahti, E. I. , et al., WO9110727-A.
Leong and Baxter, Mol. Endocrinol., 6(6):870-876 (1992).
Baxter, J. Biol. Chem., 264(20):11843-11848 (1989).
Khosravi, et al., J. Clin. Endocrinol Metab., 82(12):3944-3951 (1997).
Artavanistsakonas, S. and Rothberg, J. M., WO9210518-A1.
Suzuki, et al., J. Biol. Chem. (U.S.), 271(37):22522 (1996).
Tayar, N., et al., Mol. Cell Endocrinol., (Ireland), 125(1-2):65-70 (Dec. 1996).
Miura, Y., et al., Nippon Rinsho (Japan), 54(7):1784-1789 (Jul. 1996).
Harris, P. C., et al., J. Am. Soc. Nephrol., 6(4):1125-1133 (Oct. 1995).
Klein et al., Proc. Natl. Acad. Sci., 93:7108-7113 (1996).
GenBank, Accession No. P—AAC88958, WO200070050-A1, Pub Date: Nov. 23, 2000, Baker, K.P. et al.
GenBank, Accession No. P—AAC91467, WO200073452-A2, Pub Date: Dec. 7, 2000, Ashkenazi, A.J. et al.
GenBank, Accession No. P—AAA49724, WO200037638-A2, Pub Date: Jun. 29, 2000, Ashkenazi, A.J. et al.
GenBank, Accession No. P—AAA77613, WO200032221-A2, Pub Date: Jun. 8, 2000, Ashkenazi, A.J. et al.
GenBank, Accession No. P—AAC58591, WO200053758-A2, Pub Date: Sep. 14, 2000, Ashkenazi, A.J. et al.
GenBank, Accession No. AX055398, WO 0073452-A, Pub Date: Dec. 7, 2000, Ashkenazi, A.J. et al.
GenBank, Accession No. AX047642, WO 0070050-A1, Pub Date: Nov. 23, 2000, Baker, K.P. et al.
GenBank, Accession No. BC011787, Direct Submission, Submitted: Jul. 30, 2001, Strausberg, R.L. et al.
GenBank, Accession No. P—AAF90642, WO200109162-A2, Pub Date: Feb. 8, 2001, Fraser, C.C. et al.
Dayhoff, Accession No. P—AAB49891, WO200070050-A1, Pub Date: Nov. 23, 2000, Baker, K.P. et al.
Dayhoff, Accession No. P—AAB50908, WO200073452-A2, Pub Date: Dec. 7, 2000, Ashkenazi, Avi et al.
Dayhoff, Accession No. P—AAU04589, WO200151520-A2, Pub Date: Jul. 19, 2001, Strittmatter, S.M.
Dayhoff, Accession No. P—AAY95345, WO200037638-A2, Pub Date: Jun. 29, 2000, Ashkenazi, A.J. et al.
Dayhoff, Accession No. P—AAB24410, WO200032221-A2, Pub Date: Jun. 8, 2000, Ashkenazi, A.J. et al.
Dayhoff, Accession No. P—AAB44301, WO200053756-A2, Pub Date: Sep. 14, 2000, Ashkenazi, A.J. et al.
Dayhoff, Accession No. P—AAY41745, WO09946281-A2, Pub Date: Sep. 16, 1999, Wood, W.I. et al.
Dayhoff, Accession No. AAH11787.1, Direct Submission, Submitted: Jul. 30, 2001, Strausberg, R.
Dayhoff, Accession No. AAG53612.1, Direct Submission, Submitted: Jun. 29, 2000, Strittmatter, S.M.
Dayhoff, Accession No. CAC59981.1, WO 0151250-A1, Pub Date: Jul. 19, 2001, Strittmatter, S.M.
Dayhoff, Accession No. P—AAB87087, WO 200109162-A2, Pub Date: Feb. 8, 2001, Fraser, C.C. et al.
Dayhoff, Accession No. P—AAB87164, WO 200109162-A2, Pub Date: Feb. 8, 2001, Fraser, C.C. et al.
Dayhoff, Accession No. P—AAB87162, WO 200109162-A2, Pub Date: Feb. 8, 2001, Fraser, C.C. et al.
Dayhoff, Accession No. P—AAB87165, WO 200109162-A2, Pub Date: Feb. 8, 2001, Fraser, C.C. et al.
Dayhoff, Accession No. P—AAB87163, WO 200109162-A2, Pub Date: Feb. 8, 2001, Fraser, C.C. et al.
Dayhoff, Accession No. P—AAB33426, WO 20053758-A2, Pub Date: Sep. 14, 2000, Ashkenazi, Avi et al.
Dayhoff, Accession No. P—AAB87089, WO 200109162-A2, Pub Date: Feb. 8, 2001, Fraser, C.C. et al.
Dayhoff, Accession No. P—AAB87101, WO 200109162-A2, Pub Date: Feb. 8, 2001, Fraser, C.C. et al.

Affiliated with

Also associated with

Rating

PRO526 nucleic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with PRO526 nucleic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRO526 nucleic acids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3952186